Teva Pharmaceutical Industries Ltd
TEVA34.690USD
-0.110-0.32%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
39.80BMarket Cap
28.17P/E TTM
More Details of Teva Pharmaceutical Industries Ltd Company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Info
Ticker SymbolTEVA
Company nameTeva Pharmaceutical Industries Ltd
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Number of employees33892
Security typeDepository Receipt
Fiscal year-endFeb 06
Address124 Dvora Hanevi'a St.
CityTEL AVIV-YAFO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIsrael
Postal code6944020
Phone97239148213
Websitehttps://www.tevapharm.com/
Ticker SymbolTEVA
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Company Executives of Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+9632.00%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
+14280.00%
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+9632.00%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
+14280.00%
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
Other
458.00M
10.22%
By RegionUSD
Name
Revenue
Proportion
United States
2.48B
55.40%
Europe
1.24B
27.57%
International Markets
558.00M
12.46%
Other
205.00M
4.58%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
Other
458.00M
10.22%
Shareholding Stats
Updated: Sun, Jan 11
Updated: Sun, Jan 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Harel Insurance Investments and Financial Services Ltd
3.91%
Phoenix Investment and Finances Ltd
3.57%
Menora Mivtachim Insurance Ltd.
3.38%
Migdal Insurance and Financial Holdings Ltd
3.25%
BlackRock Institutional Trust Company, N.A.
3.04%
Other
82.84%
Shareholders
Shareholders
Proportion
Harel Insurance Investments and Financial Services Ltd
3.91%
Phoenix Investment and Finances Ltd
3.57%
Menora Mivtachim Insurance Ltd.
3.38%
Migdal Insurance and Financial Holdings Ltd
3.25%
BlackRock Institutional Trust Company, N.A.
3.04%
Other
82.84%
Shareholder Types
Shareholders
Proportion
Investment Advisor
23.09%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
10.42%
Insurance Company
6.65%
Research Firm
2.35%
Family Office
1.86%
Pension Fund
1.56%
Bank and Trust
0.85%
Sovereign Wealth Fund
0.24%
Other
40.48%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1165
666.08M
57.93%
-136.04M
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Harel Insurance Investments and Financial Services Ltd
37.70M
3.29%
+4.31M
+12.90%
Sep 30, 2025
Phoenix Investment and Finances Ltd
41.30M
3.6%
+3.53M
+9.36%
Sep 30, 2025
Menora Mivtachim Insurance Ltd.
38.92M
3.39%
-18.47M
-32.19%
Sep 30, 2025
Migdal Insurance and Financial Holdings Ltd
32.58M
2.84%
+3.90M
+13.58%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
34.92M
3.04%
+1.03M
+3.04%
Sep 30, 2025
Clal Insurance Enterprises Holdings Ltd.
31.49M
2.74%
-876.00K
-2.71%
Sep 30, 2025
Lingotto Investment Management LLP
28.59M
2.49%
+431.87K
+1.53%
Sep 30, 2025
Rubric Capital Management LP
24.65M
2.15%
-1.35M
-5.19%
Sep 30, 2025
PointState Capital LP
20.71M
1.81%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
20.19M
1.76%
-30.45M
-60.13%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
View more
iShares MSCI Israel ETF
Proportion7.76%
VanEck Israel ETF
Proportion7.5%
VanEck Pharmaceutical ETF
Proportion3.79%
First Trust WCM Developing World Equity ETF
Proportion3.16%
First Trust WCM International Equity ETF
Proportion2.64%
ARK Israel Innovative Technology ETF
Proportion1.81%
WealthTrust DBS Long Term Growth ETF
Proportion1.42%
WisdomTree International Multifactor Fund
Proportion0.77%
iShares Health Innovation Active ETF
Proportion0.69%
iShares MSCI Intl Value Factor ETF
Proportion0.46%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
